Takeshita, Y., Tanaka, T., Wakakuri, H., Kita, Y., Kanamori, T., & Takamura, T. (2020). Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study. J Diabetes Investig.
Citação norma ChicagoTakeshita, Yumie, Takeo Tanaka, Hitomi Wakakuri, Yuki Kita, Takehiro Kanamori, and Toshinari Takamura. "Metabolic and Sympathovagal Effects of Bolus Insulin Glulisine Versus Basal Insulin Glargine Therapy in People With Type 2 Diabetes: A Randomized Controlled Study." J Diabetes Investig 2020.
MLA CitationTakeshita, Yumie, et al. "Metabolic and Sympathovagal Effects of Bolus Insulin Glulisine Versus Basal Insulin Glargine Therapy in People With Type 2 Diabetes: A Randomized Controlled Study." J Diabetes Investig 2020.